Instead of strengthening America’s trade position, Rep. McKinley's tariff triggered retaliation from other nations. Prices rose, particularly for middle- and lower-income Americans, and political backlash followed.
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Monday and uncover the stocks that are leading the way in terms of trading volume and market attention.
On the eve of the scheduled implementation of Trump tariffs on Canada, China and Mexico, equity investors are selling US shares in favor of European stocks.
Diagnostics company Guardant Health (NASDAQGH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 30.2% year on year to $201.8 million. Its GAAP loss of $0.90 per share was 12.4% below analysts’ consensus estimates.
Siyata Mobile Inc. (NASDAQSYTA) shares are trading higher Monday after the company provided additional details regarding a key term of its proposed merger with Core Gaming.
The ISM index fell -0.6 to 50.3, and the more leading new orders subindex fell from its very strong January reading of 55.1 back into contraction at 48.6, the lowest reading in four months.
MicroCloud Hologram shares are trading higher on Monday after the company announced a multi-million dollar investment in cryptocurrency, blockchain and quantum computing.
BioXcel Therapeutics, Inc. (NASDAQBTAI) shares are trading higher Monday following news that the U.S. Food and Drug Administration (FDA) has concluded its inspection of a site involved in the company's Phase 3 TRANQUILITY II trial.
Shares of digital media measurement and analytics provider DoubleVerify (NYSEDV)
jumped 10.4% in the afternoon session after the stock rebounded from its large post-earnings drop as Bank of America upgraded its rating from Sell to Hold, citing limited downsides, given the combination of "conservative guidance, forthcoming product cycles, and a duopoly position in the ad verification market." The large post-earnings drop is likely spurring some investors to look at the name and re-assess at the lower price and valuation multiple. However, we note that the stock is still down from where it traded before it reported.
Shares of leading designer of graphics chips Nvidia (NASDAQNVDA)
fell 7.9% in the afternoon session after market volatility continued, with the stock seemingly affected by the broader downturn as the Nasdaq declined 1.3% in another negative session. Tepid economic manufacturing and construction data released Monday sparked another wall of worry about the US economy.
AbbVie partners with Gubra in a $2.2 billion deal to develop GUB014295, an amylin analog for obesity. The move marks AbbVie's entry into the competitive weight-loss market.
NVIDIA stock is trading lower on Monday. Reportedly, Chinese buyers are acquiring the company's advanced artificial intelligence (AI) chips despite U.S. export restrictions.
